Rating Change
HC Wainwright & Co. reiterated its Buy rating on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) on October 15, 2026.
reiterateNASDAQ:PRAX
HC Wainwright & Co. Reiterates Buy Rating on Praxis Precision Medicines, Inc. (PRAX)
HC Wainwright & Co. reiterated its Buy rating on Praxis Precision Medicines, Inc.
At publication ·
What changed
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $246.93
- Market capitalization
- $5.7B
At a glance
Key takeaways
- HC Wainwright & Co. maintained its Buy rating on Praxis Precision Medicines (PRAX) on October 15, 2026.
Market Context
Praxis Precision Medicines, Inc. operates in the Healthcare sector. The stock currently trades at $246.93 with a market capitalization of $5.7B.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Praxis Precision Medicines, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Praxis Precision Medicines, Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 15, 2026 | HC Wainwright & Co. | Buy | N/A |
| Oct 06, 2026 | BTIG | Buy | N/A |
| Oct 06, 2026 | HC Wainwright & Co. | Buy | N/A |
| Sep 24, 2026 | HC Wainwright & Co. | Buy | N/A |
| Sep 24, 2026 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PRAX Stock Page
Frequently Asked Questions
What does the Buy rating mean for PRAX?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Praxis Precision Medicines, Inc. (NASDAQ:PRAX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PRAX forecast page.